Hemispherian Secures GLIX1 Patent for Solid Tumors
19 Nov 2025 //
BUSINESSWIRE
Biolinerx Receives USPTO Notice For GLIX1 Cancer Treatment
17 Nov 2025 //
PR NEWSWIRE
Celgene`s phase 3 AML test chalks up a win
14 Sep 2019 //
FIERCE BIOTECH
Xinxiang Tuoxin Biochemical Co. Ltd on USFDA import alert
06 Apr 2016 //
FDA

Market Place
Sourcing Support